| Liquid biopsy in ovarian cancer using circulating tumor DNA and cells: Ready for prime time? DB Asante, L Calapre, M Ziman, TM Meniawy, ES Gray Cancer letters, 2019 | 153 | 2019 |
| Circulating tumour DNA (ctDNA) as a liquid biopsy for melanoma L Calapre, L Warburton, M Millward, M Ziman, ES Gray Cancer letters 404, 62-69, 2017 | 129 | 2017 |
| Correlation between circulating tumour DNA and metabolic tumour burden in metastatic melanoma patients AC McEvoy, L Warburton, Z Al-Ogaili, L Celliers, L Calapre, MR Pereira, ... BMC cancer 18 (1), 726, 2018 | 94 | 2018 |
| Circulating melanoma cell subpopulations: their heterogeneity and differential responses to treatment ES Gray, AL Reid, S Bowyer, L Calapre, K Siew, R Pearce, L Cowell, ... Journal of Investigative Dermatology 135 (8), 2040-2048, 2015 | 84 | 2015 |
| Detection and prognostic role of heterogeneous populations of melanoma circulating tumour cells CA Aya-Bonilla, M Morici, X Hong, AC McEvoy, RJ Sullivan, J Freeman, ... British Journal of Cancer, 1-9, 2020 | 55 | 2020 |
| Circulating tumor DNA predicts outcome from first-, but not second-line treatment and identifies melanoma patients who may benefit from combination immunotherapy G Marsavela, J Lee, L Calapre, SQ Wong, MR Pereira, AC McEvoy, ... Clinical Cancer Research 26 (22), 5926-5933, 2020 | 54 | 2020 |
| Sensitive droplet digital PCR method for detection of TERT promoter mutations in cell free DNA from patients with metastatic melanoma AC McEvoy, L Calapre, MR Pereira, T Giardina, C Robinson, MA Khattak, ... Oncotarget 8 (45), 78890, 2017 | 54 | 2017 |
| Locus‐specific concordance of genomic alterations between tissue and plasma circulating tumor DNA in metastatic melanoma L Calapre, T Giardina, C Robinson, AL Reid, Z Al‐Ogaili, MR Pereira, ... Molecular oncology 13 (2), 171-184, 2019 | 47 | 2019 |
| Clinical application of circulating tumor cells and circulating tumor DNA in uveal melanoma A Beasley, T Isaacs, MA Khattak, JB Freeman, R Allcock, FK Chen, ... JCO Precision Oncology 2, 1-12, 2018 | 47 | 2018 |
| Heat stress: a risk factor for skin carcinogenesis L Calapre, ES Gray, M Ziman Cancer letters 337 (1), 35-40, 2013 | 46 | 2013 |
| Prognostic value of HLA-I homozygosity in patients with non-small cell lung cancer treated with single agent immunotherapy A Abed, L Calapre, J Lo, S Correia, S Bowyer, A Chopra, M Watson, ... Journal for immunotherapy of cancer 8 (2), 2020 | 41 | 2020 |
| Heat-mediated reduction of apoptosis in UVB-damaged keratinocytes in vitro and in human skin ex vivo L Calapre, ES Gray, S Kurdykowski, A David, P Hart, P Descargues, ... BMC dermatology 16 (1), 6, 2016 | 32 | 2016 |
| Detection of clinical progression through plasma ctDNA in metastatic melanoma patients: a comparison to radiological progression G Marsavela, AC McEvoy, MR Pereira, AL Reid, Z Al-Ogaili, L Warburton, ... British journal of cancer, 1-8, 2021 | 30 | 2021 |
| The epigenetic landscape of circulating tumour cells SS Vasantharajan, MR Eccles, EJ Rodger, S Pattison, JL McCall, ES Gray, ... Biochimica et Biophysica Acta (BBA)-Reviews on Cancer 1875 (2), 188514, 2021 | 29 | 2021 |
| Genomic analysis of circulating tumor DNA using a melanoma-specific UltraSEEK oncogene panel ES Gray, T Witkowski, M Pereira, L Calapre, K Herron, D Irwin, ... The Journal of Molecular Diagnostics 21 (3), 418-426, 2019 | 25 | 2019 |
| Stopping targeted therapy for complete responders in advanced BRAF mutant melanoma L Warburton, TM Meniawy, L Calapre, M Pereira, A McEvoy, M Ziman, ... Scientific Reports 10 (1), 1-8, 2020 | 21 | 2020 |
| Intra-and intertumoral heterogeneity of liver metastases in a patient with uveal melanoma revealed by single-cell RNA sequencing W Lin, AB Beasley, NM Ardakani, E Denisenko, L Calapre, M Jones, ... Molecular Case Studies 7 (5), a006111, 2021 | 17 | 2021 |
| Changes in plasma hydroxyproline and plasma cell-free DNA concentrations after higher-versus lower-intensity eccentric cycling G Mavropalias, L Calapre, M Morici, T Koeda, WCK Poon, OR Barley, ... European Journal of Applied Physiology 121 (4), 1087-1097, 2021 | 17 | 2021 |
| The prognostic impact of circulating tumour dna in melanoma patients treated with systemic therapies—beyond braf mutant detection G Marsavela, PA Johansson, MR Pereira, AC McEvoy, AL Reid, ... Cancers 12 (12), 3793, 2020 | 13 | 2020 |
| Detection of BRAF splicing variants in plasma-derived cell-free nucleic acids and extracellular vesicles of melanoma patients failing targeted therapy therapies ME Clark, H Rizos, MR Pereira, AC McEvoy, G Marsavela, L Calapre, ... Oncotarget 11 (44), 4016, 2020 | 13 | 2020 |
